secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0000950170-25-038316
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q4 2024 revenue $519.9M (+8.6%), net income $29.2M vs loss; Adj. EBITDA +42.8%; FY2025 guidance
--------------------------------------------------------------------------------

- Q4 revenue $519.9M (+8.6% YoY); gross margin $171.7M (33.0%) up 15.7%.
- Q4 net income $29.2M vs net loss $25.7M; diluted EPS $0.14 vs ($0.13).
- Q4 adjusted net income $11.1M (+$14.3M); adjusted diluted EPS $0.05 vs ($0.02).
- Q4 Adjusted EBITDA $55.2M (+42.8%); FY2024 revenue >$2B, Adj. EBITDA >$183M.
- FY2025 guidance: revenue $2.10–$2.12B; Adj. EBITDA $190–$194M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017025038316/0000950170-25-038316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017025038316/avah-20250313.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-038316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer